中医药治疗椎-基底动脉供血不足性眩晕研究进展  

Clinical Research Progress in the Treatment of Vertebrobasilar Insufficiency Vertigo with Traditional Chinese Medicine

作　　者：丁狼 DING Lang(Nanchang Hongdu Hospital of Traditional Chinese Medicine,Nanchang,Jiangxi,China,330038)

机构地区：[1]南昌市洪都中医院,江西南昌330038

出　　处：《河南中医》2024年第9期1441-1445,共5页Henan Traditional Chinese Medicine

基　　金：江西省中医药管理局项目(2020A264)。

摘　　要：中医药治疗椎-基底动脉供血不足性眩晕主要包括中药汤剂、中成药、中药注射液等,这些药物具有养血、补肾、活血通络、平肝定眩、滋阴潜阳等功效。中医药治疗椎-基底动脉供血不足性眩晕的作用机制为提高临床效果、改善血液流变、加快椎-基底动脉血流速度等。目前,研究存在以下不足:现有指标研究深度不够,缺乏多中心、大样本的随机对照研究,缺乏远期随访,亦存在疗效判定标准不统一等问题。今后,应加强大样本、多中心的临床研究,统一规范疗效判定标准,加大定量研究,延长随访时间,为中医药治疗椎-基底动脉供血不足性眩晕提供更多高质量的证据支持。The treatments of vertebrobasilar insufficiency vertigo with traditional Chinese medicine(TCM) primarily include Chinese medicinal decoction,Chinese patent medicine,Chinese medicinal injection,etc.These treatments are effective in nourishing blood,tonifying the kidney,promoting blood circulation and dredging collaterals,calming the liver,stabilizing vertigo,nourishing yin,and subduing yang.The mechanisms by which TCM treats vertebrobasilar insufficiency vertigo include improving clinical efficacy,enhancing hemorheology,and accelerating blood flow in the vertebrobasilar arteries.However,current research faces several limitations,such as insufficient depth of existing indicator studies,lack of multi-center,large sample randomized controlled trials,lack of long-term follow-ups,and inconsistent efficacy evaluation criteria.In the future,it is necessary to strengthen large-scale and multi-center clinical research,standardize efficacy standards,increase quantitative research,extend follow-ups,and provide more high-quality evidence support for the treatment of vertebrobasilar artery insufficiency vertigo with TCM.

关 键 词：椎-基底动脉供血不足性眩晕 中药汤剂 中成药 中药注射 

分 类 号：R274.9[医药卫生—中西医结合]